Market Tracker

12/11 5:15pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

29.97
Delayed Data
As of 4:00pm ET
 -0.52 / -1.71%
Today’s Change
24.31
Today|||52-Week Range
41.20
+3.92%
Year-to-Date

Today’s Trading

Previous close30.49
Today’s open30.50
Day’s range29.76 - 30.87
Volume1,307,260
Average volume (3 months)1,523,197
Market cap$3.7B
Dividend yield--
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)-43.56%
Earnings growth (this year)-3.38%
Earnings growth (next 5 years)+38.29%
Revenue growth (last year)+28,311.48%
P/E ratioNM
Price/Sales192.80
Price/Book7.14

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...+0.29+0.28%
AKRXAkorn Inc-0.28-0.85%
AGNPRAAllergan plc+18.33+3.06%
MNKMallinckrodt Plc+0.84+3.77%
Data as of 4:02pm ET, 12/11/2017

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$17.3M
Annual profit (last year)-$271.4M
Net profit margin-1,565.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Senior VP-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts